HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats.

Abstract
Acute neuropathology following experimental traumatic brain injury results in the rapid necrosis of cortical tissue at the site of injury. This primary injury is exacerbated in the ensuing hours and days via the progression of secondary injury mechanism(s) leading to significant neurological dysfunction. Recent evidence from our laboratory demonstrates that the immunosuppressant cyclosporin A significantly ameliorates cortical damage following traumatic brain injury. The present study extends the previous findings utilizing a unilateral controlled cortical impact model of traumatic brain injury in order to establish a dose-response curve and optimal dosing regimen of cyclosporin A. Following injury to adult rats, cyclosporin A was administrated at various dosages and the therapy was initiated at different times post-injury. In addition to examining the effect of cyclosporin A on the acute disruption of the blood-brain barrier following controlled cortical impact, we also assessed the efficacy of cyclosporin A to reduce tissue damage utilizing the fluid percussion model of traumatic brain injury. The findings demonstrate that the neuroprotection afforded by cyclosporin A is dose-dependent and that a therapeutic window exists up to 24h post-injury. Furthermore, the optimal cyclosporin dosage and regimen markedly reduces disruption of the blood-brain barrier acutely following a cortical contusion injury, and similarly affords significant neuroprotection following fluid percussion injury. These findings clearly suggest that the mechanisms responsible for tissue necrosis following traumatic brain injury are amenable to pharmacological intervention.
AuthorsP G Sullivan, A G Rabchevsky, R R Hicks, T R Gibson, A Fletcher-Turner, S W Scheff
JournalNeuroscience (Neuroscience) Vol. 101 Issue 2 Pg. 289-95 ( 2000) ISSN: 0306-4522 [Print] United States
PMID11074152 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Neuroprotective Agents
  • Cyclosporine
Topics
  • Animals
  • Blood-Brain Barrier (drug effects, physiology)
  • Brain Injuries (drug therapy, pathology, physiopathology)
  • Cell Death (drug effects, physiology)
  • Cerebral Cortex (drug effects, injuries, pathology, physiopathology)
  • Cyclosporine (administration & dosage)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Male
  • Nerve Degeneration (drug therapy, pathology, physiopathology, prevention & control)
  • Neuroprotective Agents (administration & dosage)
  • Percussion (adverse effects)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: